331 related articles for article (PubMed ID: 30133059)
1. Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process.
Zhang Y; Taylor BV; Simpson S; Blizzard L; van der Mei I
Eur J Neurol; 2019 Jan; 26(1):155-161. PubMed ID: 30133059
[TBL] [Abstract][Full Text] [Related]
2. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.
Hughes J; Jokubaitis V; Lugaresi A; Hupperts R; Izquierdo G; Prat A; Girard M; Duquette P; Grand'Maison F; Grammond P; Sola P; Ferraro D; Ramo-Tello C; Trojano M; Slee M; Shaygannejad V; Boz C; Lechner-Scott J; Van Pesch V; Pucci E; Solaro C; Verheul F; Terzi M; Granella F; Spitaleri D; Alroughani R; Jun JK; Fambiatos A; Van der Walt A; Butzkueven H; Kalincik T;
JAMA Neurol; 2018 Nov; 75(11):1407-1415. PubMed ID: 30083762
[TBL] [Abstract][Full Text] [Related]
3. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.
Nazareth TA; Rava AR; Polyakov JL; Banfe EN; Waltrip Ii RW; Zerkowski KB; Herbert LB
Mult Scler Relat Disord; 2018 Nov; 26():219-234. PubMed ID: 30368080
[TBL] [Abstract][Full Text] [Related]
4. Pain Intensity and Pain Interference in People With Progressive Multiple Sclerosis Compared With People With Relapsing-Remitting Multiple Sclerosis.
Knowles LM; Phillips KM; Herring TE; Alschuler KN; Jensen MP; Turner AP; Ehde DM
Arch Phys Med Rehabil; 2021 Oct; 102(10):1959-1964. PubMed ID: 34048792
[TBL] [Abstract][Full Text] [Related]
5. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
[TBL] [Abstract][Full Text] [Related]
6. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.
Novotna M; Paz Soldán MM; Abou Zeid N; Kale N; Tutuncu M; Crusan DJ; Atkinson EJ; Siva A; Keegan BM; Pirko I; Pittock SJ; Lucchinetti CF; Noseworthy JH; Weinshenker BG; Rodriguez M; Kantarci OH
Neurology; 2015 Aug; 85(8):722-9. PubMed ID: 26208962
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Planche V; Gibelin M; Cregut D; Pereira B; Clavelou P
Eur J Neurol; 2016 Feb; 23(2):282-9. PubMed ID: 25903918
[TBL] [Abstract][Full Text] [Related]
8. Relapses and progression of disability in multiple sclerosis.
Confavreux C; Vukusic S; Moreau T; Adeleine P
N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
[TBL] [Abstract][Full Text] [Related]
9. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
D'hooghe MB; Haentjens P; Nagels G; Garmyn M; De Keyser J
Mult Scler; 2012 Apr; 18(4):451-9. PubMed ID: 21952096
[TBL] [Abstract][Full Text] [Related]
10. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Ruano L; Portaccio E; Goretti B; Niccolai C; Severo M; Patti F; Cilia S; Gallo P; Grossi P; Ghezzi A; Roscio M; Mattioli F; Stampatori C; Trojano M; Viterbo RG; Amato MP
Mult Scler; 2017 Aug; 23(9):1258-1267. PubMed ID: 27738090
[TBL] [Abstract][Full Text] [Related]
11. Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Feys P; Bibby BM; Baert I; Dalgas U
Eur J Phys Rehabil Med; 2015 Apr; 51(2):207-10. PubMed ID: 25180640
[TBL] [Abstract][Full Text] [Related]
12. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
[TBL] [Abstract][Full Text] [Related]
13. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.
Zamboni P; Galeotti R; Menegatti E; Malagoni AM; Gianesini S; Bartolomei I; Mascoli F; Salvi F
J Vasc Surg; 2009 Dec; 50(6):1348-58.e1-3. PubMed ID: 19958985
[TBL] [Abstract][Full Text] [Related]
14. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
[TBL] [Abstract][Full Text] [Related]
15. Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis?
Rasova K; Brandejsky P; Havrdova E; Zalisova M; Rexova P
Mult Scler; 2005 Apr; 11(2):213-21. PubMed ID: 15794397
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis patients with and without sexual dysfunction: are there any differences?
Demirkiran M; Sarica Y; Uguz S; Yerdelen D; Aslan K
Mult Scler; 2006 Apr; 12(2):209-14. PubMed ID: 16629425
[TBL] [Abstract][Full Text] [Related]
17. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
Kowalec K; McKay KA; Patten SB; Fisk JD; Evans C; Tremlett H; Marrie RA;
Neurology; 2017 Dec; 89(24):2455-2461. PubMed ID: 29117961
[TBL] [Abstract][Full Text] [Related]
19. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.
Hawton A; Green C; Telford CJ; Wright DE; Zajicek JP
Mult Scler; 2012 Jun; 18(6):853-61. PubMed ID: 22108867
[TBL] [Abstract][Full Text] [Related]
20. The relationship of age with the clinical phenotype in multiple sclerosis.
Scalfari A; Lederer C; Daumer M; Nicholas R; Ebers GC; Muraro PA
Mult Scler; 2016 Nov; 22(13):1750-1758. PubMed ID: 26869531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
